O. Maíz
YOU?
Author Swipe
View article: Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases
Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases Open
Objective The spectrum of GCA includes various vascular phenotypes. Tocilizumab (TCZ) is the only biologic therapy currently approved, regardless of phenotype. We aimed to assess the effectiveness of TCZ in various phenotypes. Methods This…
View article: Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease
Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease Open
Background: The leading cause of blindness due to non-infectious uveitis is cystoid macular edema (CME). Behçet’s disease (BD) is one of the most commonly conditions related to CME. Objectives: To compare the effectiveness and safety of ad…
View article: Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients Open
In patients with RA-ILD, ABA seems to be equally effective regardless of the route of administration.
View article: AB0709 EFFECTIVENESS OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS IN CLINICAL PRACTICE. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW
AB0709 EFFECTIVENESS OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS IN CLINICAL PRACTICE. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW Open
Background Patients with giant cell arteritis (GCA) can relapse despite glucocorticoids, methotrexate and tocilizumab treatment. The JAK/STAT signalling pathway is involved in the pathogenesis of GCA, and JAK inhibitors (JAKi) are a potent…
View article: AB1470 JANUS KINASE INHIBITORS IN SEVERE INFLAMMATORY OCULAR PATHOLOGY. MULTICENTER STUDY AND LITERATURE REVIEW
AB1470 JANUS KINASE INHIBITORS IN SEVERE INFLAMMATORY OCULAR PATHOLOGY. MULTICENTER STUDY AND LITERATURE REVIEW Open
Background Inflammatory ocular pathology (IOP) includes internal (uveitis) and external (mainly ocular surface pathology) involvement. IOP may be severe ocular conditions refractory to conventional and biological immunosuppressants. Janus …
View article: AB1464 COMPARATIVE STUDY OF ADALIMUMAB, INFLIXIMAB AND CERTOLIZUMAB IN THE TREATMENT OF CYSTOID MACULAR EDEMA DUE TO BEHÇET’S DISEASE
AB1464 COMPARATIVE STUDY OF ADALIMUMAB, INFLIXIMAB AND CERTOLIZUMAB IN THE TREATMENT OF CYSTOID MACULAR EDEMA DUE TO BEHÇET’S DISEASE Open
Background the main cause of blindness in non-infectious uveitis is cystoid macular edema (CME). Behçet's disease (BD) is one of the most common diseases associated with CME [1-3]. Objectives to compare efficacy and safety of Adalimumab (A…
View article: Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients Open
Objectives To evaluate effectiveness and safety of certolizumab pegol (CZP) in uveitis due to immune-mediated inflammatory diseases (IMID). Methods Multicentre study of CZP-treated patients with IMID uveitis refractory to conventional immu…
View article: Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients Open
IVMP pulse therapy was effective and safe, and achieved rapid control of NIU.
View article: Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients Open
Background: Visual involvement is the most feared complication of giant cell arteritis (GCA). Information on the efficacy of tocilizumab (TCZ) for this complication is scarce and controversial. Objective: We assessed a wide series of GCA t…